Group | Control | Low | High | |||
---|---|---|---|---|---|---|
Analyte | Male | Female | Male | Female | Male | Female |
Blood Cell Counts | ||||||
RBC (102/μl) | 1108 ± 85 | 942 ± 124 | 1039 ± 111 | 834 ± 72 | 1019 ± 117 | 881 ± 130 |
WBC (104/μl) | 89 ± 20 | 62 ± 15 | 94 ± 29 | 56 ± 18 | 92 ± 21 | 63 ± 22 |
Hb (g/dl) | 18.1 ± 1.4 | 16.8 ± 1.8 | 17.5 ± 2.2 | 15.2 ± 1.3 | 17.1 ± 2.0 | 16.8 ± 2.6 |
HTC (%) | 54.4 ± 3.8 | 49.5 ± 5.9 | 52.1 ± 6.6 | 44.6 ± 4.0 | 51.7 ± 6.4 | 47.3 ± 7.5 |
PLT (104/μl) | 78.4 ± 18.0 | 92.4 ± 18.7 | 85.5 ± 20.9 | 90.9 ± 18.7 | 93.2 ± 31.2 | 81.2 ± 19.5 |
MCH (pg) | 16.3 ± 0.4 | 17.9 ± 0.6 | 16.8 ± 0.6 | 18.3 ± 0.8 | 16.8 ± 0.7 | 18.3 ± 0.9 |
NE% (%) | 14.9 ± 5.8 | 12.5 ± 6.5 | 10.4 ± 3.1 | 13.7 ± 3.5 | 17.1 ± 4.8 | 17.5 ± 6.3 |
EO% (%) | 0.9 ± 0.6 | 1.2 ± 0.9 | 0.2 ± 0.4* | 0.7 ± 0.6 | 0.3 ± 0.3* | 1.1 ± 0.6 |
BA% (%) | 0.5 ± 0.6 | 0.5 ± 0.5 | 0.5 ± 0.4 | 0.8 ± 0.3 | 0.5 ± 0. | 30.2 ± 0.3 |
MO% (%) | 12.2 ± 4.2 | 12.5 ± 3.5 | 8.8 ± 2.4* | 13.7 ± 3.0 | 11.5 ± 4.8 | 13.1 ± 6.3 |
LY% (%) | 69.3 ± 7.9 | 71.9 ± 6.6 | 75.4 ± 5.3 | 67.9 ± 6.3 | 68.5 ± 4.8 | 66.2 ± 8.9 |
BALF Cell Counts | ||||||
BC (104/ml) | 39.4 ± 45.1 | 12.5 ± 10.0 | 27.1 ± 37.6 | 39.9 ± 18.1* | 21.8 ± 13.1 | 28.4 ± 23.5 |
WBC% (%) | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |